Ursula Ney und Ceo - Info zur Person - Personensuche Yasni.de

(1 - 8 von 11

)

Genkyotex' Lead Product Shows Promise in OsteoporosisStartupticker.ch

www.startupticker.ch

— In our studies we found that NOX4 was induced in human osteoporosis, and inhibiting NOX4 could reduce bone loss in mice.” Dr. Ursula Ney, CEO of ... › news

Genkyotex Announces Top-Line Results of Business Wirebusinesswire.com

www.businesswire.com

— Ursula Ney, CEO of Genkyotex. ”The data from the Phase 2 study shows a statistically significant effect on markers of liver injury and — Ursula Ney, CEO of Genkyotex. “We are also now well positioned to advance other promising candidates into our NOX inhibitor pipeline.” The ... › ...

FDA approves pertuzumab - NatureNature Journal

www.nature.com

However, Ursula Ney, CEO of one small biotech, GenKyoTex of Geneva, says this is an opportunity for the anti-oxidative drugs. › articles › nbt

Genkyotex Raises CHF 20 Million ($21 Million) | Fierce BiotechFierceBiotech

www.fiercebiotech.com

Ursula Ney, CEO of Genkyotex. "We are also now well positioned to advance other promising candidates into our NOX inhibitor pipeline." The Company expects to ... › ...

Les stock hi-res stock photography and images - Page 5 - AlamyAlamy

www.alamy.com

RM 2E699WC–Ursula Ney, CEO of biotech company Genkyotex, poses at the company headquarters in Plan-les-Ouates in Geneva July 26, › stock-photo › les-stock